Large Valeant Pharmaceuticals (NYSE: VRX) investors were said to have met up with Pershing Square's Bill Ackman weeks before the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE